Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Blanke

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 6, 2021
Letters to the EditorAshley Sweet, Charles Blanke, Brian Kelly, et al.
Southern Medical Journal|August 23, 2002
Metastatic breast cancer manifested as refractory anemia and gastric polypsTara B Karamlou, John T Vetto, Christopher Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597Gregory A Masters, Lieven Declerck, Charles Blanke, et al.
Clinical Drug Investigation|January 16, 2007
Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumoursDaniel M Huse, Margaret von Mehren, Gregory Lenhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2024
Correlative Science in the Cooperative Group System: Re-Engineering for SuccessPeter J O'Dwyer, Norman Wolmark, Douglas S Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
End points in advanced colon cancer clinical trials: a review and proposalCarmen Allegra, Charles Blanke, Marc Buyse, et al.
Clinical Colorectal Cancer|January 16, 2013
Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405Katherine Van Loon, Devin Wigler, Donna Niedzwiecki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
Cancer Medicine|February 4, 2020
Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and eraMichael E Roth, Joseph M Unger, Ann M O'Mara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 2, 2017
Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancerJoseph S Bubalo, Jon D Herrington, Marc Takemoto, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics|January 6, 2021
Letters to the EditorAshley Sweet, Charles Blanke, Brian Kelly, et al.
Southern Medical Journal|August 23, 2002
Metastatic breast cancer manifested as refractory anemia and gastric polypsTara B Karamlou, John T Vetto, Christopher Corless, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: Eastern Cooperative Oncology Group Trial 1597Gregory A Masters, Lieven Declerck, Charles Blanke, et al.
Clinical Drug Investigation|January 16, 2007
Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumoursDaniel M Huse, Margaret von Mehren, Gregory Lenhart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2024
Correlative Science in the Cooperative Group System: Re-Engineering for SuccessPeter J O'Dwyer, Norman Wolmark, Douglas S Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
End points in advanced colon cancer clinical trials: a review and proposalCarmen Allegra, Charles Blanke, Marc Buyse, et al.
Clinical Colorectal Cancer|January 16, 2013
Comparison of dietary and lifestyle habits among stage III and metastatic colorectal cancer patients: findings from CALGB 89803 and CALGB 80405Katherine Van Loon, Devin Wigler, Donna Niedzwiecki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2012
Benefits and adverse events in younger versus older patients receiving adjuvant chemotherapy for colon cancer: findings from the Adjuvant Colon Cancer Endpoints data setJoleen Hubbard, David M Thomas, Greg Yothers, et al.
Cancer Medicine|February 4, 2020
Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and eraMichael E Roth, Joseph M Unger, Ann M O'Mara, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 2, 2017
Phase II open label pilot trial of aprepitant and palonosetron for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic FOLFOX chemotherapy for the treatment of colorectal cancerJoseph S Bubalo, Jon D Herrington, Marc Takemoto, et al.
Pageof 4